These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17823403

  • 1. Comparison of the in vitro susceptibility of rodent isolates of Pseudomonas aeruginosa and Pasteurella pneumotropica to enrofloxacin.
    Sasaki H, Kawamoto E, Kunita S, Yagami K.
    J Vet Diagn Invest; 2007 Sep; 19(5):557-60. PubMed ID: 17823403
    [Abstract] [Full Text] [Related]

  • 2. Elimination of Pasteurella pneumotropica from a mouse barrier facility by using a modified enrofloxacin treatment regimen.
    Towne JW, Wagner AM, Griffin KJ, Buntzman AS, Frelinger JA, Besselsen DG.
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):517-22. PubMed ID: 25255075
    [Abstract] [Full Text] [Related]

  • 3. An outbreak of Pasteurella pneumotropica in genetically modified mice: treatment and elimination.
    Matsumiya LC, Lavoie C.
    Contemp Top Lab Anim Sci; 2003 Mar; 42(2):26-8. PubMed ID: 19757621
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of various therapeutic regimens in eliminating Pasteurella pneumotropica from the mouse.
    Goelz MF, Thigpen JE, Mahler J, Rogers WP, Locklear J, Weigler BJ, Forsythe DB.
    Lab Anim Sci; 1996 Jun; 46(3):280-5. PubMed ID: 8799933
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial testing of selected fluoroquinolones against Pseudomonas aeruginosa isolated from canine otitis.
    McKay L, Rose CD, Matousek JL, Schmeitzel LS, Gibson NM, Gaskin JM.
    J Am Anim Hosp Assoc; 2007 Jun; 43(6):307-12. PubMed ID: 17975212
    [Abstract] [Full Text] [Related]

  • 6. Implementation of a PCR assay of Pasteurella pneumotropica to accurately screen for contaminated laboratory mice.
    Ouellet M, Cowan M, Laporte A, Faubert S, Héon H.
    Lab Anim (NY); 2011 Sep 21; 40(10):305-12. PubMed ID: 22358207
    [Abstract] [Full Text] [Related]

  • 7. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
    Muramatsu H, Horii T, Takeshita A, Hashimoto H, Maekawa M.
    Chemotherapy; 2005 May 21; 51(2-3):70-5. PubMed ID: 15870499
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
    Epstein SP, Bottone EJ, Asbell PA.
    Eye Contact Lens; 2006 Sep 21; 32(5):240-4. PubMed ID: 16974157
    [Abstract] [Full Text] [Related]

  • 9. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV, Ballal M, Shivananda PG.
    Indian J Pathol Microbiol; 2007 Jan 21; 50(1):94-6. PubMed ID: 17474274
    [Abstract] [Full Text] [Related]

  • 10. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy.
    Macy JD, Weir EC, Compton SR, Shlomchik MJ, Brownstein DG.
    Comp Med; 2000 Feb 21; 50(1):49-55. PubMed ID: 10987669
    [Abstract] [Full Text] [Related]

  • 11. From the [Pasteurella] pneumotropica complex to Rodentibacter spp.: an update on [Pasteurella] pneumotropica.
    Benga L, Sager M, Christensen H.
    Vet Microbiol; 2018 Apr 21; 217():121-134. PubMed ID: 29615244
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece.
    Vingopoulou EI, Delis GA, Batzias GC, Kaltsogianni F, Koutinas A, Kristo I, Pournaras S, Saridomichelakis MN, Siarkou VI.
    Vet Microbiol; 2018 Jan 21; 213():102-107. PubMed ID: 29291992
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
    Trott DJ, Moss SM, See AM, Rees R.
    Aust Vet J; 2007 Nov 21; 85(11):464-6. PubMed ID: 17970852
    [No Abstract] [Full Text] [Related]

  • 14. Comparative analysis of Pasteurella pneumotropica isolates from laboratory mice and rats.
    Sasaki H, Kawamoto E, Tanaka Y, Sawada T, Kunita S, Yagami K.
    Antonie Van Leeuwenhoek; 2009 May 21; 95(4):311-7. PubMed ID: 19234758
    [Abstract] [Full Text] [Related]

  • 15. Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs.
    Harada K, Shimizu T, Kataoka Y, Takahashi T.
    Acta Vet Scand; 2012 Mar 20; 54(1):16. PubMed ID: 22433170
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J, Walker RD, Blickenstaff K, Bodeis-Jones S, Zhao S.
    Vet Microbiol; 2008 Sep 18; 131(1-2):164-72. PubMed ID: 18395369
    [Abstract] [Full Text] [Related]

  • 17. Assessment of rpoB and 16S rRNA genes as targets for PCR-based identification of Pasteurella pneumotropica.
    Dole VS, Banu LA, Fister RD, Nicklas W, Henderson KS.
    Comp Med; 2010 Dec 18; 60(6):427-35. PubMed ID: 21262128
    [Abstract] [Full Text] [Related]

  • 18. Elimination of Pasteurella pneumotropica from a contaminated mouse colony by oral administration of Enrofloxacin.
    Ueno Y, Shimizu R, Nozu R, Takahashi S, Yamamoto M, Sugiyama F, Takakura A, Itoh T, Yagami K.
    Exp Anim; 2002 Jul 18; 51(4):401-5. PubMed ID: 12221935
    [Abstract] [Full Text] [Related]

  • 19. Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
    Jerzsele Á, Pásztiné-Gere E.
    Acta Microbiol Immunol Hung; 2015 Mar 18; 62(1):45-55. PubMed ID: 25823453
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar 18; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.